Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Rachet

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 19, 2011
How many deaths would be avoidable if socioeconomic inequalities in cancer survival in England were eliminated? A national population-based study, 1996-2006Libby Ellis, Michel P Coleman, Bernard Rachet
Lancet (London, England)|December 7, 2014
40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011: a population-based studyManuela Quaresma, Michel P Coleman, Bernard Rachet
Oncotarget|July 1, 2016
What might explain deprivation-specific differences in the excess hazard of breast cancer death amongst screen-detected women? Analysis of patients diagnosed in the West Midlands region of England from 1989 to 2011Melanie Morris, Laura M Woods, Bernard Rachet
Health Statistics Quarterly|December 21, 2007
Cancer survival indicators by Cancer Network: a methodological perspectiveLibby Ellis, Bernard Rachet, Michel P Coleman
Gastroenterology|March 27, 2007
Survival from malignant digestive endocrine tumors in England and Wales: a population-based studyCôme Lepage, Bernard Rachet, Michel Philippe Coleman
Cancer Epidemiology|May 2, 2024
An index of cancer survival to measure progress in cancer control: A tutorialManuela Quaresma, Francisco Javier Rubio, Bernard Rachet
European Journal of Cancer Care|February 9, 2019
Opportunities for reducing emergency diagnoses of colon cancer in women and men: A data-linkage study on pre-diagnostic symptomatic presentations and benign diagnosesCristina Renzi, Georgios Lyratzopoulos, Willie Hamilton, et al.
BMC Cancer|December 4, 2016
Analysing population-based cancer survival - settling the controversiesMaja Pohar Perme, Jacques Estève, Bernard Rachet
European Urology|July 31, 2013
Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.: beta-blockers and prostate cancer survival--interpretation of competing risks modelsKrishnan Bhaskaran, Bernard Rachet, Stephen Evans, et al.
Journal of Gastrointestinal Cancer|January 5, 2023
Variations in the Type of Adjuvant Chemotherapy Among Stage III Colon Cancer Patients in EnglandSyreen Hassan, Anne Miles, Bernard Rachet, et al.
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|November 19, 2011
How many deaths would be avoidable if socioeconomic inequalities in cancer survival in England were eliminated? A national population-based study, 1996-2006Libby Ellis, Michel P Coleman, Bernard Rachet
Lancet (London, England)|December 7, 2014
40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011: a population-based studyManuela Quaresma, Michel P Coleman, Bernard Rachet
Oncotarget|July 1, 2016
What might explain deprivation-specific differences in the excess hazard of breast cancer death amongst screen-detected women? Analysis of patients diagnosed in the West Midlands region of England from 1989 to 2011Melanie Morris, Laura M Woods, Bernard Rachet
Health Statistics Quarterly|December 21, 2007
Cancer survival indicators by Cancer Network: a methodological perspectiveLibby Ellis, Bernard Rachet, Michel P Coleman
Gastroenterology|March 27, 2007
Survival from malignant digestive endocrine tumors in England and Wales: a population-based studyCôme Lepage, Bernard Rachet, Michel Philippe Coleman
Cancer Epidemiology|May 2, 2024
An index of cancer survival to measure progress in cancer control: A tutorialManuela Quaresma, Francisco Javier Rubio, Bernard Rachet
European Journal of Cancer Care|February 9, 2019
Opportunities for reducing emergency diagnoses of colon cancer in women and men: A data-linkage study on pre-diagnostic symptomatic presentations and benign diagnosesCristina Renzi, Georgios Lyratzopoulos, Willie Hamilton, et al.
BMC Cancer|December 4, 2016
Analysing population-based cancer survival - settling the controversiesMaja Pohar Perme, Jacques Estève, Bernard Rachet
European Urology|July 31, 2013
Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.: beta-blockers and prostate cancer survival--interpretation of competing risks modelsKrishnan Bhaskaran, Bernard Rachet, Stephen Evans, et al.
Journal of Gastrointestinal Cancer|January 5, 2023
Variations in the Type of Adjuvant Chemotherapy Among Stage III Colon Cancer Patients in EnglandSyreen Hassan, Anne Miles, Bernard Rachet, et al.
Pageof 15